Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2012 Jan 21;259(3):329–337. doi: 10.1016/j.taap.2012.01.010

Fig. 1. NaF reduces the viability of mESCs in a dose- and time-dependent manner.

Fig. 1

(A) Cells were incubated in the presence and absence of 1 or 2 mM NaF and at various incubation times. Viability was determined by the WST-8 assay. In addition, mESCs were treated with the increasing concentrations (0–5 mM) of NaF for 24 h (B) or with 2 mM for various incubation times (0–72 h) (C) and then processed for the WST-8 assay. ***p < 0.001 vs. the untreated controls.